Matthew Lang - Chief Business Officer at Lyell Immunopharma, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Business Officer
Stock Symbol
LYEL on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Matthew Lang since 11/21/2023

Holdings reported by Matthew Lang for Lyell Immunopharma, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 50K $114K $2.28 Feb 9, 2024 Direct
Option (right to buy) 500K Feb 9, 2024 Direct Common Stock

Transactions reported by Matthew Lang for Lyell Immunopharma, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.